Labeling issues lead to MedReleaf cannabis recall in Quebec

On: April 6, 2020

Aurora Cannabis subsidiary MedReleaf Corp. is recalling two lots of cannabis sold in Quebec under the San Rafael ’71 brand for incorrect labeling. The two recalled 3.5-gram lots of Island Sweet Skunk cannabis were sold March 26-27 by Quebec’s government-operated Société québécoise du cannabis (SQDC) retailer. Labels on those lots misstated the amount of THC […]

Labeling issues lead to MedReleaf cannabis recall in Quebec is a post from: Marijuana Business Daily: Financial, Legal & Cannabusiness news for cannabis entrepreneurs

Previous Post: COVID-19 crisis effectively freezes European GMP cannabis inspections in Canada, elsewhere

Next Post: DEA loosens rules on prescription CBD drug Epidiolex

Comments are closed, but trackbacks and pingbacks are open.